Dr. Tamorah Lewis Awarded a RWJF Grant to Support her Neonatal Precision Therapeutics Research
Congratulations to Tamorah Lewis MD, PhD, for recently being awarded the Harold Amos Medical Faculty Development Program grant from the Robert Wood Johnson Foundation. The Harold Amos Medical Faculty Development Program (AMFDP) was created to increase the number of faculty from historically disadvantaged backgrounds who can achieve senior rank in academic medicine, dentistry, or nursing and who will encourage and foster the development of succeeding classes of such physicians, dentists, and nurse-scientists. The program opened its doors in 1983 to its first cohort of eight physicians. Thirty-three years and 280 alumni later, program graduates are full professors, chairs of departments, leaders of Institutes within the National Institutes of Health, and individuals nationally and internationally known for their valuable contributions to biomedical research, health services research, and clinical investigation.
With the four-year grant awarded to Dr. Lewis, she will be afforded the protected time and resources needed to establish herself as a clinician researcher at Children’s Mercy Hospital. The grant will support her research program investigating the effects of age and genetics on exposure and clinical response to nonsteroidal anti-inflammatory drugs in premature infants. With mentorship in both the Divisions of Neonatology and Clinical Pharmacology, Toxicology and Therapeutic Innovation at CMH, and the Annual Harold Amos Scholars retreat, Dr Lewis will progress in her career development as a clinical and translational researcher in neonatal and perinatal pharmacology.
Support for this research was provided <in part> by the Robert Wood Johnson Foundation. The views expressed here do not necessarily reflect the views of the Foundation.
Children’s Mercy Kansas City is ranked as one of “America's Best Children's Hospitals” in all 10 specialties rated by U.S. News & World Report and has received MagnetTM recognition for excellence in nursing services four consecutive times. With 366 licensed beds and a medical staff of more than 750 pediatric subspecialists, we care for children from all 50 states and from around the world. In addition, our leadership in pediatric genomic medicine and individualized pediatric therapeutics is driving research and innovation in neonatology, nephrology, endocrinology, gastroenterology, neurology, heart, cancer and other subspecialties to transform outcomes for children. Children’s Mercy also is nationally recognized for innovation in psychosocial care and creating a family-centered environment focused on the unique needs of hospitalized children and their families. Our love for children powers everything we do, inspiring our research, innovations and our everyday care. Because love has no limits. And with it, neither do we.